25 June 2022>: Clinical Research
Serum TP53 Protein Level as a Sensitive Biomarker for the Diagnosis of Myocardial Damage in Children
Xianglin Zeng EF* , Chunwang Lin AEG** , Yanna Sun BD* , Jianping Zhang CFDOI: 10.12659/MSM.936248
Med Sci Monit 2022; 28:e936248
Table 1 Characteristics of the patient population at admission.
All patients | Myocardial damage | Non-myocardial damage | P | |
---|---|---|---|---|
Number of subjects | 100 | 50 | 50 | – |
Age, y | 7.86±1.6 | 8.23±3.12 | 8.05±1.4 | 0.26 |
Male % | 53.7 | 56.0 | 51.4 | 0.74 |
Heart rate, beats/min | 110±26 | 126±28 | 95±25 | |
Systolic blood pressure, mmHg | 102±14.3 | 98±15.7 | 105±12.8 | 0.44 |
Arterial oxygen saturation, % | 84±12 | 78±15 | 90±9 | |
TP53, ng/L | 5.25±0.65 | 10.20±1.20 | 0.30±0.10 | |
NT-proBNP, ng/L(M) | 306.6 | 505.3 | 107.8 | |
cTnI, μg/L | 0.13±0.04 | 0.23±0.13 | 0.02±0.01 | |
CK-MB,IU/L | 20.27±4.71 | 28.30±5.13 | 12.24±4.29 | |
Plasma glucose, mmol/L | 6.5±1.2 | 6.8±1.6 | 6.2±0.8 | 0.57 |
Alanine transaminase, U/L | 57±15 | 66±13 | 48±17 | |
C reaction protein, mg/L | 28±6.9 | 31±6.5 | 25±7.3 | |
Procalcitonin, mg/L | 5±2.9 | 6±3.5 | 4±2.3 | |
Blood lactic acid, mmol/L | 3±1.3 | 3±1.5 | 3±1.1 | 0.67 |
Ejection fraction, % | 55±3.1 | 45±3.8 | 65±2.4 | |
E peak/A peak | 1.4±0. | 1.5±0.2 | 1.3±0.2 | 0.26 |